My Gene Counsel
PrivateLast Round
Convertible Debt
Apr 11, 2018
Total Funding Raised
$900,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
My Gene Counsel operates in Healthcare & Life Sciences and is based in New Haven, Connecticut. Its latest recorded funding round was a Convertible Debt round in April 2018.
My Gene Counsel is a digital health company that provides scalable, AI-enabled genetic counseling and testing management solutions for clinicians, health systems, and patients.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Healthcare Analytics, Patient Engagement, Telemedicine
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
My Gene Counsel Comparables
Compare My Gene Counsel with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DNAvisit | 84% | |
| Genome Medical | 81% | |
| Igentify | 81% |
For institutional investors. Book with your work email.
My Gene Counsel Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Apr 11, 2018 | ||||
| Convertible Debt | Jul 21, 2017 | ||||
| Convertible Debt | Sep 12, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
My Gene Counsel Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 147% MoM, reaching 5.1K.
- Nov 9, 2025
Monthly visitors grew 206% MoM, reaching 7.6K.
For institutional investors. Book with your work email.
My Gene Counsel Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about My Gene Counsel's valuation, stock price, and market status.
Is My Gene Counsel a public or private company?
My Gene Counsel is a private company.
What is the current stock price of My Gene Counsel?
My Gene Counsel is a private company, so its shares have no public market price. Caplight tracks My Gene Counsel's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is My Gene Counsel worth (valuation)?
Valuation information for My Gene Counsel is not publicly available.
Can I buy My Gene Counsel stock?
My Gene Counsel shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was My Gene Counsel's last funding round?
My Gene Counsel's most recent funding round was Convertible Debt on April 11, 2018.
Who are the main investors in My Gene Counsel?
Key investors in My Gene Counsel include Connecticut Innovations.
Will My Gene Counsel IPO soon?
No public IPO plans have been announced for My Gene Counsel.
How can I track My Gene Counsel secondary market activity?
Caplight tracks bids, offers, and trades in My Gene Counsel's shares on secondary markets.